Resmed Inc Stock Investor Sentiment

RMD Stock  USD 178.85  1.24  0.70%   
About 60% of ResMed's investor base is looking to short. The analysis of overall sentiment of trading ResMed Inc stock suggests that many investors are alarmed at this time. ResMed's investor sentiment overview provides quick insight into current market opportunities from investing in ResMed Inc. The current market sentiment, together with ResMed's historical and current headlines, can help investors time the market. In addition, many technical investors use ResMed Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Panic Vs Confidence

40

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use ResMed's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward ResMed Inc.
ResMed stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of ResMed daily returns and investor perception about the current price of ResMed Inc as well as its diversification or hedging effects on your existing portfolios.

ResMed Historical Sentiment

Although ResMed's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding ResMed, such as negative comments on social media and news outlets, may cause fear in the market and push ResMed's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of ResMed.
  

ResMed Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards ResMed can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

ResMed Inc Historical Investor Sentiment

Investor biases related to ResMed's public news can be used to forecast risks associated with an investment in ResMed. The trend in average sentiment can be used to explain how an investor holding ResMed can time the market purely based on public headlines and social activities around ResMed Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ResMed's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ResMed and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average ResMed news discussions. The higher the estimate score, the more favorable the investor's outlook on ResMed.

ResMed Maximum Pain Price across 2024-04-19 Option Contracts

ResMed's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of ResMed close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of ResMed's options.
over a month ago at finance.yahoo.com         
Mental Health Screening Market Worth 1.8 billion MarketsandMarkets.
Yahoo News
over a month ago at investing.com         
Earnings call Nyxoah achieves robust sales growth, eyes FDA approval
Investing News at Macroaxis
over a month ago at fool.com.au         
Morgans names more of the best ASX 200 shares to buy in March
fool News
over a month ago at benzinga.com         
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
benzinga news
over a month ago at thelincolnianonline.com         
Element Capital Management LLC Sells 7,424 Shares of ResMed Inc.
news
over a month ago at thelincolnianonline.com         
Disposition of tradable shares by Michael Rider of ResMed at 180.0 subject to Rule 16b-3
news
over a month ago at thelincolnianonline.com         
Axxcess Wealth Management LLC Makes New 1.81 Million Investment in ResMed Inc.
news
over a month ago at thelincolnianonline.com         
Toronto Dominion Bank Lowers Stake in ResMed Inc.
news
over a month ago at fool.com.au         
These ASX 200 shares could rise 20 percent to 50
fool News
over a month ago at fool.com.au         
Disposition of 200 shares by Michael Rider of ResMed at 173.25 subject to Rule 16b-3
fool News
over a month ago at forbes.com         
Required Minimum Distributions Defined How To Calculate Them
Usa forbes News
over a month ago at fool.com.au         
Here are 2 high-quality ASX 200 blue chip shares that analysts are bullish on
fool News
over a month ago at stockhead.com.au         
ASX Large Caps Star, Harvey Norman, Bitcoin rally but CPI tonight will decide if correction is comin...
news
over a month ago at fool.com.au         
Goldman Sachs says this US stock is replacing Tesla in the Magnificent Seven
fool News
over a month ago at smh.com.au         
ASX rallies in late trade to close less than a point shy of record high
news
Far too much social signal, news, headlines, and media speculation about ResMed that are available to investors today. That information is available publicly through ResMed media outlets and privately through word of mouth or via ResMed internal channels. However, regardless of the origin, that massive amount of ResMed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ResMed news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ResMed relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ResMed's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ResMed alpha.

ResMed Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Global Ventilators Market Report 2024-2029 The Ventilators Market is One of the Fastest-Growing Segments in the Medical Devices Market, with a Predicted CAGR of...
03/07/2024
 
ResMed dividend paid on 14th of March 2024
03/14/2024
3
Insider Trading
03/15/2024
4
Disposition of 200 shares by Michael Rider of ResMed at 173.25 subject to Rule 16b-3
03/18/2024
5
Why Cettire, Harvey Norman, Orora, and ResMed shares are sinking today
04/02/2024
6
2 ASX shares I cant ignore CSL and RMD
04/05/2024
7
Why two brokers have named this ASX 200 stock as a best buy
04/09/2024
8
Closing Bell Iron ore, health stocks out in front gold explorer Forrestania doubles
04/10/2024
9
Acquisition by Michael Farrell of 55468 shares of ResMed at 148.9 subject to Rule 16b-3
04/12/2024
10
Hoping to beat the ASX 200 Id consider buying these 3 ASX shares
04/16/2024
11
Amylyxs Relvyvrio data was, as promised, disappointing
04/17/2024
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:
Check out ResMed Hype Analysis, ResMed Correlation and ResMed Performance.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for ResMed Stock analysis

When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Transaction History
View history of all your transactions and understand their impact on performance
Is ResMed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.07)
Dividend Share
1.84
Earnings Share
6.04
Revenue Per Share
30.633
Quarterly Revenue Growth
0.125
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.